摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-benzyl-2-(3,4-dichlorophenyl)morpholine | 390408-06-7

中文名称
——
中文别名
——
英文名称
4-benzyl-2-(3,4-dichlorophenyl)morpholine
英文别名
——
4-benzyl-2-(3,4-dichlorophenyl)morpholine化学式
CAS
390408-06-7
化学式
C17H17Cl2NO
mdl
——
分子量
322.234
InChiKey
UDVBTGBRPOCRRD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    423.8±45.0 °C(Predicted)
  • 密度:
    1.263±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.57
  • 重原子数:
    21.0
  • 可旋转键数:
    3.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    12.47
  • 氢给体数:
    0.0
  • 氢受体数:
    2.0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Discovery and initial structure–Activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists
    摘要:
    Thrombin is the most potent agonist of platelet activation, and its effects are predominantly mediated by platelet thrombin receptors. Therefore, antagonists of the thrombin receptor have potential utility for the treatment of thrombotic disorders. Screening of combinatorial libraries revealed 2 to be a potent antagonist of the thrombin receptor. Modifications of this structure produced 11k, which inhibits thrombin receptor stimulated secretion and aggregation of platelets. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(01)00538-8
  • 作为产物:
    描述:
    2-溴-3',4'-二氯苯乙酮 在 sodium tetrahydroborate 作用下, 以 甲醇乙腈 为溶剂, 生成 4-benzyl-2-(3,4-dichlorophenyl)morpholine
    参考文献:
    名称:
    Discovery and initial structure–Activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists
    摘要:
    Thrombin is the most potent agonist of platelet activation, and its effects are predominantly mediated by platelet thrombin receptors. Therefore, antagonists of the thrombin receptor have potential utility for the treatment of thrombotic disorders. Screening of combinatorial libraries revealed 2 to be a potent antagonist of the thrombin receptor. Modifications of this structure produced 11k, which inhibits thrombin receptor stimulated secretion and aggregation of platelets. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(01)00538-8
点击查看最新优质反应信息